Tibet Rhodiola Pharmaceutical Holding Co.
public_traded
Tibet Rhodiola Pharmaceutical Holding Co. is publicly traded on SHH under ticker 600211.SS.
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.